Debra Frimerman - 01 Mar 2023 Form 4 Insider Report for Cibus, Inc. (CBUS)

Signature
Suzette McNally, Attorney-in-Fact for Debra Frimerman
Issuer symbol
CBUS
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 20:25:16 UTC
Previous filing
04 Jan 2023
Next filing
08 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBUS Common Stock Award $0 +5,533 +42% $0.000000 18,772 31 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -80,000 -100% 0 01 Mar 2023 Common Stock 80,000 $4.55 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Award +80,000 80,000 01 Mar 2023 Common Stock 80,000 $4.55 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -27,000 -100% 0 01 Mar 2023 Common Stock 27,000 $8.05 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Award +27,000 27,000 01 Mar 2023 Common Stock 27,000 $8.05 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -250,000 -100% 0 01 Mar 2023 Common Stock 250,000 $1.27 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Award +250,000 250,000 01 Mar 2023 Common Stock 250,000 $1.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Debra Frimerman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023.
F2 The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.